Nov. 25, 2011 biOasis announces Non-Brokered Private Placement
Vancouver, BC–(Business Wire)– biOasis Technologies Inc. (TSX.V:BTI) is pleased to announce a non-brokered private placement of up to 2,250,000 units at a price of $0.45 per unit for gross proceeds of up to $1,012,500 with an overallotment of up to 20%. Each unit will consist of one common share and one full common share purchase… Read more »
Sep. 2, 2011 Option Grant – biOasis Technologies Inc.
Vancouver, BC–(Business Wire)– biOasis Technologies Inc. (TSX.V:BTI) announces that it has granted options to its officers, employees, consultants and members of the board of directors. A total of 2,275,000 options have been granted effective at the close of business on September 1st, 2011. The options are exercisable at a price of $0.52 per share until… Read more »
Feb. 24, 2011 Shareholder Update – 2010 Year in Review
Vancouver, British Columbia–(Business Wire)– The management of biOasis Technologies Inc. (TSX.V: BTI) is pleased to provide this year in review update to highlight the corporate accomplishments made in 2010. Highlights: Significantly higher concentrations of p97 successfully transported across the Blood-Brain Barrier Commercial development of Cognitest™ (Alzheimer’s disease blood test) underway $1,029,287 private placement completed Dr.… Read more »